Top Markets
Coin of the day
Pulse Biosciences, Inc. Pulse Biosciences, Inc.

Pulse Biosciences, Inc.

PLSE
Rang in aandelen #4731
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Aandeelprijs
$48.46
Laatst gesynchroniseerd: 2026-08-26
Marktkapitalisatie
$3.35B
Verandering (1 dag)
-1.09%
Verandering (1 jaar)
205.77%
Land
US
Handel Pulse Biosciences, Inc. (PLSE)

Categorie

Dividendrendementgeschiedenis voor Pulse Biosciences, Inc. (PLSE)
Het dividendrendement (TTM) van Pulse Biosciences, Inc. (aandelsymbool: PLSE) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Pulse Biosciences, Inc. (PLSE) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten